Cardlytics Continues Revenue Contraction In The Middle Of Deterioration Business Economics (NASDAQ: CDLX)

.Financial writer highly recommends marketing Cardlytics, Inc. because of decreasing device economics, earnings obstacles, as well as adverse monetary trends. Click on for this CDLX update.